-
My Account
In App
My Account
BSE Live
Dec 31, 09:25Prev. Close
62.36
Open Price
62.00
Bid Price (Qty.)
60.00 (152)
Offer Price (Qty.)
61.00 (10)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 13.34 | 19.88 | 4.44 | 1.02 | 0.10 | |
| Net CashFlow From Operating Activities | 7.92 | -5.20 | 3.17 | 7.78 | 0.37 | |
| Net Cash Used In Investing Activities | -1.26 | -1.20 | -4.43 | -1.53 | -1.81 | |
| Net Cash Used From Financing Activities | -4.52 | 12.41 | 4.94 | -6.68 | 1.72 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.14 | 6.01 | 3.68 | -0.42 | 0.28 | |
| Cash And Cash Equivalents Begin of Year | 9.98 | 3.97 | 0.29 | 0.50 | 0.13 | |
| Cash And Cash Equivalents End Of Year | 12.12 | 9.98 | 3.97 | 0.09 | 0.41 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
